Amphastar Pharmaceuticals (AMPH) Change in Cash (2013 - 2026)

Amphastar Pharmaceuticals has reported Change in Cash for 14 years, with the latest figure at $52.7 million in Q2 2026.

• On a quarterly basis, Change in Cash rose 973.47% year-over-year to $52.7 million in Q2 2026; TTM through Jun 2026 was $35.9 million, a 1961.4% increase from a year earlier, with the FY2025 full-year figure at $18.6 million, up 153.9% from the prior year.
• Change in Cash was $52.7 million for Q2 2026 at Amphastar Pharmaceuticals, up from $762000.0 in the prior quarter.
• The five-year high for Change in Cash was $119.8 million in Q3 2023, with the low at -$126.5 million in Q4 2023.
• Average Change in Cash over 5 years is $5.4 million, with a median of $1.6 million recorded in 2024.
• The largest YoY upside for Change in Cash was 1443.62% in 2023 against a maximum downside of 10938.92% in 2023.
• Over 5 years, Change in Cash stood at -$1.1 million in 2022, then plunged by 10938.92% to -$126.5 million in 2023, then jumped by 67.98% to -$40.5 million in 2024, then retreated by 13.78% to -$46.1 million in 2025, then surged by 214.29% to $52.7 million in 2026.
• The last three Change in Cash figures came in at $52.7 million (Q2 2026), $762000.0 (Q1 2026), and -$46.1 million (Q4 2025), per Business Quant data.